SILO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Silo Pharma Inc (SILO) is not a strong buy at this time for a beginner investor with a long-term strategy. The technical indicators are neutral, financial performance shows significant challenges, and there are no positive catalysts or strong trading signals to support an immediate investment decision.
The MACD is slightly positive but contracting, RSI is neutral at 45.284, and moving averages are converging. Support and resistance levels suggest limited short-term upside potential, with key resistance at 0.379 and support at 0.283. Overall, the technical outlook is neutral.
NULL identified. No recent news or significant insider/hedge fund activity.
The stock has a high probability of negative or minimal returns in the short term (-0.7% next day, -0.98% next month). Financial performance shows declining EPS (-45.45% YoY) and gross margin (-116.07% YoY).
In Q3 2025, revenue remained flat at $18,025 YoY. Net income improved slightly (-19.55% YoY), but EPS dropped significantly (-45.45% YoY), and gross margin deteriorated sharply (-116.07% YoY). Overall, the financials indicate poor growth and profitability.
No analyst rating or price target data available.
